190 related articles for article (PubMed ID: 24154938)
1. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice.
Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J
Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064
[TBL] [Abstract][Full Text] [Related]
3. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
Wu H; Yao L; Mei J; Li F
Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
[TBL] [Abstract][Full Text] [Related]
4. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
5. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
Li J; Xu H; Ke X; Tian J
J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855
[TBL] [Abstract][Full Text] [Related]
7. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
10. Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations.
Gao X; Wang S; Wang B; Deng S; Liu X; Zhang X; Luo L; Fan R; Xiang M; You C; Wei Y; Qian Z; Guo G
Biomaterials; 2015; 53():646-58. PubMed ID: 25890760
[TBL] [Abstract][Full Text] [Related]
11. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
12. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Hong M; Zhu S; Jiang Y; Tang G; Pei Y
J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
[TBL] [Abstract][Full Text] [Related]
13. Solid dispersion and effervescent techniques used to prepare docetaxel liposomes for lung-targeted delivery system: in vitro and in vivo evaluation.
Zhao L; Wei Y; Li W; Liu Y; Wang Y; Zhong X; Yu Y
J Drug Target; 2011 Apr; 19(3):171-8. PubMed ID: 20429774
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery.
Zheng D; Li D; Lu X; Feng Z
Oncol Rep; 2010 Mar; 23(3):717-24. PubMed ID: 20127011
[TBL] [Abstract][Full Text] [Related]
15. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
[TBL] [Abstract][Full Text] [Related]
16. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
Vaidya B; Vyas SP
J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
18. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB
Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J
J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556
[TBL] [Abstract][Full Text] [Related]
19. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z
Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]